HEALEY ALS Trial Surpasses 50% Dosing Ahead of Schedule

About this update from Neurizon Therapeutics Limited

Neurizon Therapeutics Limited has released a press release. View Attachment

View stock analysis, news, and events for Neurizon Therapeutics Limited